Genetic risk factors for AD identified in genome-wide association studies (GWAS) (Wightman et al., 2021), such as the E4 variant of apolipoprotein E (APOE4), also contribute to myelin dysfunction. The gene discussed is APOE; the disease is Alzheimer disease.